GWAS |
- Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL) ( 28090653)
- Brain morphology (min-P) ( 32665545)
- Brain morphology (MOSTest) ( 32665545)
- Butyrylcholinesterase levels ( 21862451)
- Cortical surface area (MOSTest) ( 32665545)
- Cortical thickness (MOSTest) ( 32665545)
- Diverticular disease ( 30177863)
- Subclinical atherosclerosis traits (other) ( 17903303)
- Subcortical volume (min-P) ( 32665545)
- Subcortical volume (MOSTest) ( 32665545)
- Trunk fat mass ( 28552196)
- Urinary albumin-to-creatinine ratio ( 31511532)
|
- Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy) ( 31835028)
- Autism spectrum disorder or schizophrenia ( 28540026)
- Bipolar disorder ( 31043756)
- Bipolar disorder with mood-incongruent psychosis ( 23092984)
- Cognitive ability, years of educational attainment or schizophrenia (pleiotropy) ( 31374203)
- Electrodermal activity ( 25387706)
- Macular thickness ( 30535121)
- Refractive error ( 32231278)
- Schizophrenia ( 28991256 29483656 30285260)
|